Collplant Biotechnologies Ltd balance sheet

At the end of fiscal 2025, Collplant Biotechnologies Ltd had total assets of $10.8m, total liabilities of $4.7m and shareholders' equity of $6.1m. It held $5.6m in cash against $0 of debt: net cash of $5.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Collplant Biotechnologies Ltd: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	5	4	3	13	30	27	12	6
Receivables	—	0	1	0	0	—	0	0
Inventory	—	1	1	1	1	1	0	1
Total current assets	—	5	6	45	32	28	13	7
Total assets	—	11	11	51	38	34	19	11
Deferred revenue (current)	1	1	0	0	—	—	—	—
Total current liabilities	—	3	3	3	3	3	3	3
Short-term debt	—	—	—	0	0	—	—	—
Long-term debt	—	0	0	0	—	—	—	—
Total debt	—	0	0	0	0	0	0	0
Total liabilities	—	7	6	6	5	6	5	5
Shareholders' equity	5	4	4	45	32	28	13	6
Net debt (negative = net cash)	−5	−4	−3	−13	−29	−27	−12	−6
Shares outstanding	—	6m	7m	11m	11m	11m	11m	13m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CLGN vs KRRO CLGN vs VTGN CLGN vs KRSA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Collplant Biotechnologies Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Collplant Biotechnologies Ltd.